Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab

View source ↗

Summary

A prospective observational study assessing the efficacy and safety of guselkumab in Crohn's disease patients who previously received ustekinumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guselkumab (guselkumab)
  • USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Inflamatory Bowel Disease, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | Status: RECRUITING